Bob Langer: Drug Delivery, Tissue Engineering, and Science

The Intersection of Science and Innovation

This episode features Bob Langer, a renowned MIT professor and one of the most highly cited scientists in history, recognized for his pioneering work in biotechnology, specifically in the fields of drug delivery systems and tissue engineering. The conversation explores how radical thinking and perseverance have led to major medical breakthroughs, bridging the gap between theoretical research and real-world application.

Overcoming Rejection and Pushing Boundaries

Langer emphasizes that great achievements are rarely devoid of failure. He shares the challenges of his early career, notably the skepticism he faced when proposing new ideas for angiogenesis inhibitors and sustained drug release.

"I thought I'd done some really good work, and Dr. Folkman thought we'd done some really good work, but it was very depressing to get rejected like that."

• The importance of developing bioassays and polymer systems to study medical problems.
• Moving beyond incremental research to tackle "big ideas" that can fundamentally shift the medical landscape.

The Future of Biotechnology

Langer provides insights into the complexity of the human body and the future of medical technology:

• Drug Delivery: The goal of creating "smart" systems that release medication in response to physiological signals, bringing elements of robotics and nanotechnology into the body.
• Tissue Engineering: Advancements in building organs and tissues from scratch using scaffolds, with successful examples like engineered human skin already approved for patient care.
• AI and Data: How artificial intelligence is becoming an increasingly powerful tool to streamline drug discovery and optimize chemical research.

Leadership and the Human Element in Science

Beyond technical achievements, Langer discusses the foundational role of mentoring and business strategy. He highlights that a successful biotech startup requires not just groundbreaking science, but also strong leadership, strategic clinical trial planning, and the ability to attract top-tier business talent. Ultimately, he finds his greatest pride in the success of his former students and their continued impact on global health.